文献速递运动医学关节外科

使用腘绳肌腱自体移植物重建前交叉韧带时富血小板血浆增强的临床结局:随机对照试验的系统评价与Meta分析

Clinical Outcomes of Platelet-Rich Plasma Augmentation in Anterior Cruciate Ligament Reconstruction Using Hamstring Tendon Autografts: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Am J Sports Med · 2026-01-01

该系统评价与Meta分析纳入11项随机对照试验、583例患者,评估富血小板血浆增强对腘绳肌腱自体移植物前交叉韧带重建临床结局的影响,结果显示富血小板血浆在3个月和6个月显著改善残余前后松弛度,但12个月时无显著差异,Lysholm评分在各时间点均无显著差异。

要点

  • 富血小板血浆增强在3个月(MD -1.12)和6个月(MD -2.00)显著改善残余前后松弛度,12个月无显著差异(MD 0.03)。
  • 富血小板血浆组与对照组Lysholm评分在3、6、12个月均无显著差异。
  • 所有Meta分析均未观察到显著异质性。

核心结论

  • 使用腘绳肌腱自体移植物行前交叉韧带重建时,富血小板血浆增强显示出潜在的短期获益,包括减少残余前后松弛度和改善影像学表现。
  • 这些效应在长期未能持续,且患者报告结局随时间推移未观察到显著差异。

研究设计与样本

  • 系统评价与Meta分析,证据等级2级。
  • 检索PubMed、Embase、Cochrane Library和Google Scholar数据库截至2024年11月1日发表的文章。
  • 纳入报告使用腘绳肌腱自体移植物行前交叉韧带重建并涉及富血小板血浆增强患者临床结局的随机对照试验。
  • 采用Cochrane协作网偏倚风险评估工具评估所选研究的方法学质量。
  • 初检1722项研究,最终纳入11项研究、583例患者。

主要发现

  • 富血小板血浆显著改善3个月残余前后松弛度(MD -1.12;95%CI -1.64至-0.60;P < .001)。
  • 富血小板血浆显著改善6个月残余前后松弛度(MD -2.00;95%CI -3.17至-0.83;P < .001)。
  • 12个月残余前后松弛度在富血小板血浆组与对照组间无显著差异(MD 0.03;95%CI -0.31至0.38;P = .847)。
  • Lysholm评分在3个月(MD 0.34;95%CI -1.20至1.87;P = .666)、6个月(MD -3.35;95%CI -10.68至3.98;P = .370)和12个月(MD 0.73;95%CI -1.41至2.88;P = .502)均无显著差异。
  • 所有Meta分析均未观察到显著异质性。

关键数值与推荐

  • 纳入标准为报告使用腘绳肌腱自体移植物行前交叉韧带重建并涉及富血小板血浆增强患者临床结局的随机对照试验。
  • 方法学质量采用Cochrane协作网偏倚风险评估工具评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anterior cruciate ligament reconstruction (ACLR) with hamstring tendon (HT) autograft is a common procedure for which interest is increasing regarding the use of platelet-rich plasma (PRP) to enhance surgical outcomes. PURPOSE: To systematically review the effect of PRP augmentation on the clinical outcomes of ACLR using HT autografts through a meta-analysis of randomized controlled trials (RCTs). STUDY DESIGN: Meta-analysis; Level of evidence, 2. METHODS: The PubMed, Embase, Cochrane Library, and Google Scholar databases were comprehensively searched for articles published up until November 1, 2024. The inclusion criteria were RCTs that reported clinical outcomes of patients undergoing ACLR with HT autografts involving PRP augmentation. The methodological quality of the selected studies was assessed using the Cochrane Collaboration's risk-of-bias tool. RESULTS: Among 1722 studies initially identified across databases, 11 studies with 583 patients were included in the analysis. The results of the meta-analysis indicated that PRP significantly improved residual anterior-posterior laxity at 3 months (mean difference [MD], -1.12; 95% CI, -1.64 to -0.60; P < .001) and 6 months (MD, -2.00; 95% CI, -3.17 to -0.83; P < .001) but not at 12 months (MD, 0.03; 95% CI, -0.31 to 0.38; P = .847). The Lysholm score did not differ significantly between the PRP and control groups at 3 months (MD, 0.34; 95% CI, -1.20 to 1.87; P = .666), 6 months (MD, -3.35; 95% CI, -10.68 to 3.98; P = .370), or 12 months (MD, 0.73; 95% CI, -1.41 to 2.88; P = .502). No significant heterogeneity was observed in any meta-analysis. CONCLUSION: PRP augmentation in ACLR using HT autografts showed potential short-term benefits including reduced residual anterior-posterior laxity and improved radiological findings. However, these effects were not sustained in the long term, and no significant differences in patient-reported outcomes were observed over time.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Han JH, Jung M, Chung K, et al. Clinical Outcomes of Platelet-Rich Plasma Augmentation in Anterior Cruciate Ligament Reconstruction Using Hamstring Tendon Autografts: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2026. PMID: 41476403. doi:10.1177/03635465251337766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。